vimarsana.com
Home
Live Updates
Immunic focusing on business development during Q4 : vimarsana.com
Immunic focusing on business development during Q4
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a...
Related Keywords
Munich
,
Bayern
,
Germany
,
London
,
City Of
,
United Kingdom
,
Daniel Vitt
,
Thomas Warner
,
Immunic Inc
,
Us Patent Office
,
Proactive London
,
Progressive Multiple
,
vimarsana.com © 2020. All Rights Reserved.